Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,421Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18COMMAVE THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10858341

Drug Substance Claim :

Drug Product Claim :

Application Number : 212994

Patent Use Code : U-3094

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

02

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10954213

Drug Substance Claim :

Drug Product Claim :

Application Number : 212994

Patent Use Code : U-3094

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

03

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10858341

Drug Substance Claim :

Drug Product Claim :

Application Number : 212994

Patent Use Code : U-3094

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

04

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10954213

Drug Substance Claim :

Drug Product Claim :

Application Number : 212994

Patent Use Code : U-3094

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

05

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10954213

Drug Substance Claim :

Drug Product Claim :

Application Number : 212994

Patent Use Code : U-3094

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

06

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10858341

Drug Substance Claim :

Drug Product Claim :

Application Number : 212994

Patent Use Code : U-3094

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

07

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10584112

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212994

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

08

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10584112

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212994

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

09

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10584113

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212994

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank

10

arrow
2024 ACI Convention
Not Confirmed

COMMAVE THERAP

Country
arrow
2024 ACI Convention
Not Confirmed

DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

US Patent Number : 10759778

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212994

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-12-09

blank